Frequent coauthors Ozgul Muneyyirci‐Delale 11 Mudar Dalloul 10 Pamela Stratton 9 Ninet Sinaii 8 Jenny Anopa 4 N. Osei-Tutu 3 V. Mniarji 2 A. Hasegawa 1 A. Gumusel 1 Ayşe Kendirci Kendirci Ceviren 1
article 2017 General pain, pelvic regional pain, gastrointestional and affective symptoms are common among women with endometriosis-related pain and may affect study retention during clinical trials ·doi:10.1016/j.fertnstert.2017.07.143
article 2016 Effect of norethindrone vs leuprolide treatment on breakthrough bleeding of women with symptomatic endometriosis ·doi:10.1016/j.fertnstert.2016.07.771
article 2015 Effect of lupron vs norethindrone treatment on lipid profile of women with symptomatic endometriosis ·doi:10.1016/j.fertnstert.2015.07.499
article 2015 Improvement in endometriosis-related pelvic pain with leuprolide or norethindrone treatment ·doi:10.1016/j.fertnstert.2015.07.507
article 2014 Health-related quality of life improvement in women with endometriosis-associated pain during treatment ·doi:10.1016/j.fertnstert.2014.07.055
article 2013 Changes in bone density in women with endometriosis on leuprolide vs norethindrone treatment ·doi:10.1016/j.fertnstert.2013.07.1700
article 2012 Changes in self-reported symptoms of women with endometriosis during treatment ·doi:10.1016/j.fertnstert.2012.07.777
article 2012 ENDOMETRIOSIS, ENDOMETRIUM, IMPLANTATION AND FALLOPIAN TUBE ·doi:10.1093/humrep/27.s2.78
book-chapter 2011 Urinary Cortisol Metablism in Women with Endometriosis ·doi:10.1210/endo-meetings.2011.part3.p26.p3-200
article 2010 Changes in quality of life (QOL) in women with symptomatic endometriosis by pain type during treatment ·doi:10.1016/j.fertnstert.2010.07.797
article 2010 Prevalence of metabolic syndrome and changes in lipid profile of women with endometriosis during treatment ·doi:10.1016/j.fertnstert.2010.07.799